NovaBay Pharmaceuticals, Inc. 3Y Revenue Growth (per Share)

3Y Revenue Growth (per Share) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Revenue Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Revenue Growth (per Share) for 2021 was -36.1% (a -5.05% decrease from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2020 was -38.02% (a -136.7% decrease from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2019 was 103.6% (a -32.85% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Revenue Growth (per Share) of NovaBay Pharmaceuticals, Inc.

Most recent 3Y Revenue Growth (per Share)of NBY including historical data for past 10 years.

Interactive Chart of 3Y Revenue Growth (per Share) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -36.1%
2020 -38.02%
2019 103.6%
2018 154.27%
2017 328.03%
2016 -17.8%
2015 -35.62%
2014 -63.24%
2013 0.0%
2012 55.33%
2011 172.03%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology